SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引:0
|
作者
Alonso-Gordoa, Teresa [1 ]
Jimenez-Fonseca, Paula [2 ]
Martinez-Trufero, Javier [3 ]
Navarro, Miguel [4 ]
Porras, Ignacio [5 ]
Rubio-Casadevall, Jordi [6 ]
Arregui Valles, Marta [7 ]
Baste, Neus [8 ]
Hernando, Jorge [9 ]
Iglesias Docampo, Lara [10 ]
机构
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain
[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain
[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain
[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain
[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain
[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain
[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
关键词
Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;
D O I
10.1007/s12094-024-03736-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.
引用
收藏
页码:2902 / 2916
页数:15
相关论文
共 50 条
  • [41] Clinical guidance for radioiodine refractory differentiated thyroid cancer
    Gild, Matti L.
    Topliss, Duncan J.
    Learoyd, Diana
    Parnis, Francis
    Tie, Jeanne
    Hughes, Brett
    Walsh, John P.
    McLeod, Donald S. A.
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (04) : 529 - 537
  • [42] An update on clinical trials of targeted therapies in thyroid cancer
    Haraldsdottir, Sigurdis
    Shah, Manisha H.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (01) : 36 - 44
  • [43] SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)
    Cassinello, J.
    Arranz, J. A.
    Piulats, J. M.
    Sanchez, A.
    Perez-Valderrama, B.
    Mellado, B.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    Lazaro, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 57 - 68
  • [44] SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
    Chacon Lopez-Muniz, J. I.
    de la Cruz-Merino, L.
    Gavila Gregori, J.
    Martinez Duenas, E.
    Oliveira, M.
    Segui Palmer, M. A.
    Alvarez Lopez, I.
    Antolin Novoa, S.
    Bellet Ezquerra, M.
    Lopez-Tarruella Cobo, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (01) : 31 - 45
  • [45] SEOM-GEICO clinical guidelines on endometrial cancer (2021)
    Pilar Barretina-Ginesta, Maria
    Quindos, Maria
    Damian Alarcon, Jesus
    Esteban, Carmen
    Gaba, Lydia
    Gomez, Cesar
    Perez Fidalgo, Jose Alejandro
    Romero, Ignacio
    Santaballa, Ana
    Jesus Rubio-Perez, Maria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 625 - 634
  • [46] MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data
    Schubert, Louis
    Mariko, Mohamed Lamine
    Clerc, Jerome
    Huillard, Olivier
    Groussin, Lionel
    CANCERS, 2023, 15 (03)
  • [47] SEOM clinical guidelines for endometrial cancer (2017)
    Santaballa, A.
    Matias-Guiu, X.
    Redondo, A.
    Carballo, N.
    Gil, M.
    Gomez, C.
    Gorostidi, M.
    Gutierrez, M.
    Gonzalez-Martin, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 29 - 37
  • [48] SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)
    Vaz-Salgado, Maria angeles
    Garcia, Belen Cigarral
    Perez, Isaura Fernandez
    Munarriz, Beatriz Jimenez
    Domarco, Paula Sampedro
    Gonzalez, Ainhoa Hernandez
    Villar, Maria Vieito
    Caro, Raquel Luque
    Delgado, Maria Luisa Villamayor
    Sanchez, Juan Manuel Sepulveda
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2856 - 2865
  • [49] SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022)
    Fernandez Montes, Ana
    Alonso, Vicente
    Aranda, Enrique
    Elez, Elena
    Alfonso, Pilar Garcia
    Gravalos, Cristina
    Maurel, Joan
    Vera, Ruth
    Vidal, Rosario
    Aparicio, Jorge
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09) : 2718 - 2731
  • [50] SEOM clinical guidelines for the treatment of anal cancer
    Maurel, Joan
    Fernandez-Martos, Carlos
    Feliu, Jaime
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08) : 525 - 527